Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Halama

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Patterns (New York, N.Y.)|December 2, 2025
Computational workflows for natural and biomedical image processing based on hypercomplex algebrasNektarios A Valous, Eckhard Hitzer, Dragoş Duşe, et al.
Oncotarget|December 9, 2014
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancerChristoph Kahlert, Maria Fiala, Gabriel Musso, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2013
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissueAnna M Sherwood, Ryan O Emerson, Dominique Scherer, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 17, 2019
Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer CellsUghur Aghamaliyev, Haristi Gaitantzi, Maria Thomas, et al.
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Cancer Research|September 20, 2017
<i>In Silico</i> Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal CancerJakob Nikolas Kather, Jan Poleszczuk, Meggy Suarez-Carmona, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
BMC Cancer|August 31, 2017
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocolJacek Hajda, Monika Lehmann, Ottheinz Krebs, et al.
Annals of Surgical Oncology|August 11, 2012
Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapyChristoph Kahlert, Eva Gaitzsch, Gunnar Steinert, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Patterns (New York, N.Y.)|December 2, 2025
Computational workflows for natural and biomedical image processing based on hypercomplex algebrasNektarios A Valous, Eckhard Hitzer, Dragoş Duşe, et al.
Oncotarget|December 9, 2014
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancerChristoph Kahlert, Maria Fiala, Gabriel Musso, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2013
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissueAnna M Sherwood, Ryan O Emerson, Dominique Scherer, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 17, 2019
Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer CellsUghur Aghamaliyev, Haristi Gaitantzi, Maria Thomas, et al.
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Cancer Research|September 20, 2017
<i>In Silico</i> Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal CancerJakob Nikolas Kather, Jan Poleszczuk, Meggy Suarez-Carmona, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
BMC Cancer|August 31, 2017
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocolJacek Hajda, Monika Lehmann, Ottheinz Krebs, et al.
Annals of Surgical Oncology|August 11, 2012
Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapyChristoph Kahlert, Eva Gaitzsch, Gunnar Steinert, et al.
Pageof 12